DIPLOMAT PHARMACY INC's ticker is DPLO and the CUSIP is 25456K101. A total of 177 filers reported holding DIPLOMAT PHARMACY INC in Q2 2017. The put-call ratio across all filers is 0.74 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $19,000 | -17.4% | 4,672 | 0.0% | 0.00% | 0.0% |
| Q3 2019 | $23,000 | -17.9% | 4,672 | 0.0% | 0.00% | 0.0% |
| Q2 2019 | $28,000 | +3.7% | 4,672 | 0.0% | 0.00% | 0.0% |
| Q1 2019 | $27,000 | -57.1% | 4,672 | 0.0% | 0.00% | -66.7% |
| Q4 2018 | $63,000 | -30.8% | 4,672 | 0.0% | 0.00% | -25.0% |
| Q3 2018 | $91,000 | -23.5% | 4,672 | 0.0% | 0.00% | -33.3% |
| Q2 2018 | $119,000 | +48.8% | 4,672 | +18.3% | 0.01% | +50.0% |
| Q1 2018 | $80,000 | +1.3% | 3,949 | 0.0% | 0.00% | 0.0% |
| Q4 2017 | $79,000 | +19.7% | 3,949 | 0.0% | 0.00% | +33.3% |
| Q3 2017 | $66,000 | +13.8% | 3,949 | 0.0% | 0.00% | 0.0% |
| Q2 2017 | $58,000 | -7.9% | 3,949 | 0.0% | 0.00% | 0.0% |
| Q1 2017 | $63,000 | – | 3,949 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Empirical Capital Management, LLC | 479,018 | $9,298,000 | 8.38% |
| Rhenman & Partners Asset Management AB | 1,174,411 | $22,795,000 | 2.28% |
| Capital Investment Advisory Services, LLC | 153,842 | $2,986,000 | 1.40% |
| Cortina Asset Management, LLC | 1,238,420 | $24,038,000 | 1.12% |
| Investors Research Corp | 92,027 | $1,786,000 | 1.02% |
| Matarin Capital Management, LLC | 697,387 | $13,536,282,000 | 0.87% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 853,687 | $16,570,000 | 0.59% |
| RICE HALL JAMES & ASSOCIATES, LLC | 809,257 | $15,708,000 | 0.56% |
| BROADVIEW ADVISORS LLC | 156,700 | $3,042,000 | 0.52% |
| FRONTIER CAPITAL MANAGEMENT CO LLC | 3,535,217 | $68,619,000 | 0.44% |